Literature DB >> 15181978

Cardiovascular autonomic regulation in patients with 3243A > G mitochondrial DNA mutation.

Kirsi Majamaa-Voltti1, Kari Majamaa, Keijo Peuhkurinen, Timo H Mäkikallio, Heikki V Huikuri.   

Abstract

BACKGROUND: Patients with the 3243A > G mutation in mitochondrial DNA (mtDNA) have an increased risk for cardiovascular morbidity and mortality. The function of the autonomic nervous system has not been evaluated in these patients. PATIENTS AND METHODS: Indices of 24-hour heart rate variability (HRV) and baroreflex sensitivity (BRS) were measured in 28 patients with 3243A > G. The results were compared to controls matched with respect to age, sex, the presence of hypertension and diabetes mellitus and the use of cardiac medication. Conventional time and spectral domain indices and fractal correlation properties of HRV were analysed.
RESULTS: In spectral analysis of HRV, the ultra-low and very-low-frequency spectral components were lower in the patients than the controls (P < 0.05 for both). Furthermore, the short-term fractal scaling exponent was lower in the patients with 3243A > G compared to the controls (1.16 +/- 0.18 versus 1.28 +/- 0.13, P < 0.01). No significant associations were found between the HRV indices and the other characteristics of the patients with 3243A > G, such as the presence of diabetes or left ventricular hypertrophy, left ventricular systolic function, the severity of the disease or the degree of 3243A > G heteroplasmy.
CONCLUSIONS: Patients with the 3243A > G mutation in mtDNA have abnormalities in the spectral and fractal characteristics of HRV suggesting altered cardiac autonomic regulation. The abnormalities are not clearly associated with clinical manifestations related to 3243A > G suggesting that mitochondrial dysfunction may affect the autonomic regulatory systems more directly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181978     DOI: 10.1080/07853890410028456

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  5 in total

Review 1.  Cardiac complications in inherited mitochondrial diseases.

Authors:  Mohaddeseh Behjati; Mohammad Reza Sabri; Masood Etemadi Far; Majid Nejati
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214

2.  Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease.

Authors:  Matthew G D Bates; Jane H Newman; Djordje G Jakovljevic; Kieren G Hollingsworth; Charlotte L Alston; Pawel Zalewski; Jacek J Klawe; Andrew M Blamire; Guy A MacGowan; Bernard D Keavney; John P Bourke; Andrew Schaefer; Robert McFarland; Julia L Newton; Douglass M Turnbull; Robert W Taylor; Michael I Trenell; Gráinne S Gorman
Journal:  Int J Cardiol       Date:  2013-06-03       Impact factor: 4.164

Review 3.  Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine.

Authors:  Jie Wang; Fei Lin; Li-Li Guo; Xing-Jiang Xiong; Xun Fan
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

4.  Mitochondrial DNA variation in sudden cardiac death: a population-based study.

Authors:  Laura Kytövuori; Juhani Junttila; Heikki Huikuri; Sirkka Keinänen-Kiukaanniemi; Kari Majamaa; Mika H Martikainen
Journal:  Int J Legal Med       Date:  2019-05-31       Impact factor: 2.686

Review 5.  The aetiology of cardiovascular disease: a role for mitochondrial DNA?

Authors:  Marianne Venter; Francois H van der Westhuizen; Joanna L Elson
Journal:  Cardiovasc J Afr       Date:  2017-08-25       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.